Cargando…
Proteomic Profiling of Plasma-Derived Biomarkers in Patients with Bladder Cancer: A Step towards Clinical Translation
Background: Bladder cancer is a life-threatening disease and a major cause of cancer-associated complications. The main challenges confronted during the clinical management of bladder cancer are associated with recurrence and disease progression to the muscle-invasive phenotype. Improved early detec...
Autores principales: | Nedjadi, Taoufik, Albarakati, Nada, Benabdelkamel, Hicham, Masood, Afshan, Alfadda, Assim A., Al-Maghrabi, Jaudah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8704559/ https://www.ncbi.nlm.nih.gov/pubmed/34947825 http://dx.doi.org/10.3390/life11121294 |
Ejemplares similares
-
Circulating proteomic signature for detection of biomarkers in bladder cancer patients
por: Nedjadi, Taoufik, et al.
Publicado: (2020) -
Plasma-Based Proteomics Profiling of Patients with Hyperthyroidism after Antithyroid Treatment
por: Masood, Afshan, et al.
Publicado: (2020) -
The prognostic impact of GSTM1/GSTP1 genetic variants in bladder Cancer
por: Albarakati, Nada, et al.
Publicado: (2019) -
Obesity Proteomics: An Update on the Strategies and Tools Employed in the Study of Human Obesity
por: Masood, Afshan, et al.
Publicado: (2018) -
Differences in the Plasma Proteome of Patients with Hypothyroidism before and after Thyroid Hormone Replacement: A Proteomic Analysis
por: Alfadda, Assim A., et al.
Publicado: (2018)